In other words, although PDE1A expression can be reduced in COPD, the residual enzyme may be hyperactivated, and together with upregulated PDE4 this leads to overall cAMP depletion at the cellular level. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.